MedTrace Logo

ExtraVascular Implantable Cardiac Defibrillator Continued Access Study

NCT05049720 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-09-10

No results posted yet for this study

Summary

This study is designed to provide continued access to the Extravascular Implantable Cardioverter Defibrillator (EV ICD) System.

Conditions

  • Tachycardia
  • Ventricular Arrythmia

Interventions

DEVICE

Defibrillation using the Extravascular ICD

VT/VF induction attempted for defibrillation testing, as well as requisite electrical testing.

Sponsors & Collaborators

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2023-07-28
Completion
2023-07-28
FDA Device
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05049720 on ClinicalTrials.gov